Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schlee

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Signal Transduction and Targeted Therapy|March 19, 2025
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapyZhaorong Chen, Rayk Behrendt, Lennart Wild, et al.
Nature Biotechnology|April 12, 2011
SiRNA delivery with exosome nanoparticlesJasper G van den Boorn, Martin Schlee, Christoph Coch, et al.
Advances in Cancer Research|April 11, 2007
c-MYC impairs immunogenicity of human B cellsMartin Schlee, Marino Schuhmacher, Michael Hölzel, et al.
Scientific Reports|July 23, 2021
An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1Julia Wegner, Thomas Zillinger, Thais Marina Schlee-Guimaraes, et al.
Scientific Reports|August 31, 2021
Author Correction: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1Julia Wegner, Thomas Zillinger, Thais Marina Schlee-Guimaraes, et al.
Advanced Drug Delivery Reviews|July 4, 2012
Exosomes as nucleic acid nanocarriersJasper G van den Boorn, Juliane Dassler, Christoph Coch, et al.
Immunological Reviews|January 6, 2009
Approaching the RNA ligand for RIG-I?Martin Schlee, Evelyn Hartmann, Christoph Coch, et al.
Blood|October 9, 2004
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
Experimental Hematology|January 18, 2006
MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
International Journal of Molecular Sciences|April 14, 2026
RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T CellsAdham Abuelola Mohamed, Christina Wallerath, Charlotte Hunkler, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Signal Transduction and Targeted Therapy|March 19, 2025
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapyZhaorong Chen, Rayk Behrendt, Lennart Wild, et al.
Nature Biotechnology|April 12, 2011
SiRNA delivery with exosome nanoparticlesJasper G van den Boorn, Martin Schlee, Christoph Coch, et al.
Advances in Cancer Research|April 11, 2007
c-MYC impairs immunogenicity of human B cellsMartin Schlee, Marino Schuhmacher, Michael Hölzel, et al.
Scientific Reports|July 23, 2021
An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1Julia Wegner, Thomas Zillinger, Thais Marina Schlee-Guimaraes, et al.
Scientific Reports|August 31, 2021
Author Correction: An epigenetic GPI anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1Julia Wegner, Thomas Zillinger, Thais Marina Schlee-Guimaraes, et al.
Advanced Drug Delivery Reviews|July 4, 2012
Exosomes as nucleic acid nanocarriersJasper G van den Boorn, Juliane Dassler, Christoph Coch, et al.
Immunological Reviews|January 6, 2009
Approaching the RNA ligand for RIG-I?Martin Schlee, Evelyn Hartmann, Christoph Coch, et al.
Blood|October 9, 2004
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
Experimental Hematology|January 18, 2006
MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
International Journal of Molecular Sciences|April 14, 2026
RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T CellsAdham Abuelola Mohamed, Christina Wallerath, Charlotte Hunkler, et al.
Pageof 7